Monday, September 6, 2010

News

News [09/03] Rochester Leads International Effort to Improve Muscular Dystrophy Treatment [09/03] Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278 [09/02] American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling [09/02] Office of Justice Programs Weekly News Brief [09/02] Sequenom to Present at Two Financial Conferences in September [09/02] Marathon Talks Yield Tentative Agreement With North Adams Regional Hospital Nurses [09/02] Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010 [09/02] ECRI Institute, AHRQ, NIH, and Others Address the Interface Between Comparative Effectiveness and Personalized Medicine [09/02] AloeSafe Hand Sanitizer is Free From Toxic Chemicals [09/02] Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development [09/02] Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies Now Available at ReportsandReports [09/02] Novelda AS to Exhibit Nanoscale Impulse Radar at EXPO 2010 in Shanghai, China [09/02] Canadian Pharmacy Intermediary SaveRxCanada.com Enhances Online Shopping System [09/02] Ektio Shoes Launches to Take Ankle Sprains Off the Court [09/02] Orexigen Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave in North America [09/02] Sigma Life Science Enters Genetically Modified Cell Market [09/01] Alere Inc. Declares Dividend on its Series B Convertible Perpetual Preferred Stock [09/01] HeartSine Donates AEDs to Kentucky Schools [09/01] Botox-maker pays $600M to resolve investigation [09/01] Pfizer buying FoldRx for undisclosed amount Back to Main

 

© 2010 by Olsson Frank Weeda Terman Bode Matz PC . All rights reserved. Disclaimer | Site Map

FirmSite® by FindLaw, a Thomson Reuters business.